Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Postoperative High-Flow Oxygen After High-Risk Abdominal and Non-Cardiac Thoracic Surgery

Official title: Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult

Run by Region Stockholm · NCT07464730 · Data updated 2026-11-12

This trial tests whether giving high-flow nasal oxygen after surgery helps prevent breathing problems in adults at high risk who had abdominal or non-cardiac thoracic surgery.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorRegion Stockholm
Government
Locations1 site (Stockholm)
StatusRecruiting
StartedApril 20, 2026
Main results expectedMarch 9, 2028
Study endsMarch 9, 2029
Registry record updatedMay 14, 2026
Trial IDNCT07464730 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) undergoing elective abdominal or non-cardiac thoracic surgery with at least two high-risk criteria and planned postoperative HFNO.

Probably not a fit

Patients without high-risk features or those who do not experience PPCs may not see a benefit from HFNO compared with standard oxygen.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares high-flow nasal oxygen (HFNO) with conventional oxygen therapy (COT) in adults undergoing high-risk elective abdominal or non-cardiac thoracic surgery lasting more than three hours. Eligible participants are 18 or older and meet at least two high-risk criteria such as age over 65, BMI over 30, or recent respiratory issues, among others. The goal is to see if HFNO reduces postoperative pulmonary complications, hypoxaemia, and need for escalation of therapy compared with COT. The trial is led by Region Stockholm with Karolinska Institutet and conducted at Karolinska University Hospital in Stockholm. Details on endpoints and exact methods are not provided in the summary.

Why it matters

Potential benefit: If HFNO proves beneficial, patients could experience fewer breathing complications and a smoother recovery after high-risk abdominal or thoracic surgery.

How similar studies have gone: Prior evidence suggests HFNO can reduce PPCs after cardiothoracic surgery, but results in general high-risk postoperative populations, especially non-cardiac procedures, are mixed or limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults (≥18 years old) scheduled for elective abdominal (laparotomy or laparoscopy), open abdominal vascular or non-cardiac thoracic surgery under general anaesthesia with an estimated duration over 3 hours.

AND

Meeting at least two of the following criteria:

* Age \> 65 years
* BMI \>30
* Preoperative SpO2 \<95 %
* Scheduled for lobectomy or pulmonary segment resection
* Respiratory tract infection the last month
* Preoperative anaemia (Hb \<100) or severe hypoalbuminemia (\<20 g/L)
* Current smoker or previous smoker with \>30 packyears
* Pulmonary disease or OSAS
* Heart failure
* Clinical frailty (CFS 4)

Exclusion Criteria:

* Not suitable for postoperative HFNO, as decided by a study member or the anaesthetist in charge (such as total nasal obstruction, skull fracture, facial injuries)
* Pregnancy
* Not able to understand the study information or sign an informed consent.
* Not able to participate with the treatment postoperatively
* Planned for delayed extubation in the intensive care
* Preoperative non-invasive ventilation due to respiratory failure or a higher level of care than a regular ward

Where it's running

  • Karolinska University Hospital
    Stockholm, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.